Results 131 to 140 of about 27,541 (198)

Potential Rad54 separation of function mutation highlights unique roles during homologous recombination. [PDF]

PLoS Genet
Hu J, Moraga D, Xu A, Peysakhova L, Crickard JB.   +4 more
europepmc   +1 more source

Transcriptome profiling of bovine preantral follicles during early folliculogenesis. [PDF]

J Anim Sci Biotechnol
Monferini N, Dey P, Donadini L, Zambelli F, Franciosi F, Lodde V, Luciano AM.   +6 more
europepmc   +1 more source

Cryo-electron microscopic visualization of RAD51 filament assembly and end-capping by XRCC3-RAD51C-RAD51D-XRCC2. [PDF]

Science
Greenhough LA, Galanti L, Liang CC, Boulton SJ, West SC.   +4 more
europepmc   +1 more source

Impact of germline <i>RAD51D</i> mutations on breast cancer: Susceptibility to DNA-damaging agents. [PDF]

Mol Ther Oncol
Jo S, Shim WC, Park S, Kweon T, Ryu WJ, Hwang Y, Kim MW, Ahn JH, Lee YJ, Lee SH, Won D, Nam EJ, Han JW, Kim TI, Park JS, Park HS.   +15 more
europepmc   +1 more source

Three-dimensional-bioprinted stiff matrix triggers PDAC radioresistance through histone H3 lysine 18 lactylation (H3K18la) potentiates RAD51 activation. [PDF]

Regen Biomater
Zhang X, Zhu H, Shi Z, Lu Y, Chang M, Li Y, Zhao Y, Yang Y, Guo Y.   +8 more
europepmc   +1 more source

Targeting the ANGPTL4/NRP1/ABL1/RAD51 axis reverses cisplatin resistance by impairing DNA damage repair in head and neck cancer. [PDF]

Proc Natl Acad Sci U S A
Asiedu EB, Kumar A, Choi A, Luciano DO, Lo K, Sharma D, Ma T, Rassool F, Sodhi A, Montaner S.   +9 more
europepmc   +1 more source

BRCA1/2 Reversion Mutations and Cancer Therapy Resistance. [PDF]

Biology (Basel)
Qi W, Yang G, Zhang Y, Han L, Mayo KH, Zeng X, Mo J.   +6 more
europepmc   +1 more source

miR-320a enhances radiosensitivity in non-small cell lung cancer by targeting RAD51 and modulating ferroptosis via GPX4. [PDF]

Sci Rep
Lv J, Zhang C, Ren X, Geng F, Li S, Wang Z, Quan X, Cheng Z, Wang R.   +8 more
europepmc   +1 more source

Repression of EGFR by new biguanide 4C potentiated ovarian cancer to PARP inhibitors through down-regulation of BRCA2 and Rad51. [PDF]

Cell Death Dis
Xiao D, Yao J, Yang X, Xie Y, Zhou X, Li D, Peng M, Wang W, Zou H, Yang X.   +9 more
europepmc   +1 more source

Targeting IP₆ signaling to destabilize homologous recombination proteins to overcome PARP inhibitor resistance. [PDF]

Nat Commun
Lee SG, Seo Y, Jeong S, Chung Y, Kong S, Kim M, Rhlee JH, Um S, Mathew BP, Maiti S, Kuram MR, Abozeid MA, Park A, Yoo JN, Khim KW, Son K, Amarsanaa E, Kim K, Hong S, Choi J, Park IB, Lee EA, Jeon JH, Park JH, Han JS, Park CY, Kim S, Choi JH, Hong SY, Seo MD, Lee H, Lee JY, Myung K.   +32 more
europepmc   +1 more source